The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction

By B. Engelhardt, L. Sorokin. Seminars in Immunopathology, 2009

750 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The blood-brain barrier in Alzheimer's disease (2017, neutral): “The brain vasculature of AD patients is characterized by a greater prevalence of collapsed or degenerated endothelium, and more severe impairment of BBB transport systems, compared to age-matched con-trol subjects (Kalaria and Hedera, 1995; Zlokovic, 2008).”
The impact of the extracellular matrix on inflammation (2010, background): “The CNS post-capillary venule consists of endothelial cells, which are joined by complex tight junctions, and an underlying endothelial basement membrane; these are further ensheathed in a second parenchymal basement membrane and a layer of astrocyte”
The blood-brain barrier. (2015, background): “Thus, further understanding is needed in terms of astrocyte involvement in supporting or inhibiting the activation and migration of immune cells as well as the repair of the affected BBB/NVU during MS/ EAE and other CNS disorders.”
The immunology of stroke: from mechanisms to translation (2011, background): “Oxidative stress and inflammatory mediators also alter the permeability of the BBB, which increases the number of pinocytotic vesicles in the cytoplasm of endothelial cells, enhancing transendothelial transpor”